UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on… Read More
The Department of Defense has awarded $1.15 million to a new research project at the University of Tennessee Health Science Center (UTHSC) that could expand the treatment options for breast cancer metastasis. Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, is the lead investigator. The project expands upon previously published research from… Read More
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer. Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Pathology in the UTHSC College… Read More
